What changed: Localised prostate cancer, very low and low risk
Every dated change on the records linked to Localised prostate cancer, very low and low risk, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Trial result4Milestone6This record1
September 2026 · 1
2024 · 2
2023 · 1
2018 · 2
2016 · 3
- 2016Trial resultCHHiPCHHiP reported
5-year biochemical or clinical failure-free survival 90.
- 2016Trial resultProtecTProtecT reported
15-year prostate-cancer mortality 3.
- 2016MilestoneProtecTProtecT: ten-year mortality about 1 percent whether monitored or treated
A milestone in how this cancer is treated.